Page not found

×

Error message

The page you requested does not exist. For your convenience, a search was performed using the query mrrpb5 global herceptin biosimilar market research report 2019.
Your search for "" gave back 1622679 results.
Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy...
Catalog: 
MRRPB5
February 2024
Price: USD 2,900.00
The global Herceptin Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Herceptin Biosimilar is...
LPI
March 2024
Price: USD 3,660.00
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. The global...
Catalog: 
MRRPB5
June 2023
Price: USD 2,900.00
Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy...
Catalog: 
MRRPB5
March 2023
Price: USD 2,900.00
The global Herceptin (Trastuzumab) and Biosimilar market size is expected to reach $ 6357.7 million by 2029, rising at a market growth of 4.6% CAGR...
GIR
June 2023
Price: USD 4,480.00
Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy...
LPI
February 2023
Price: USD 3,660.00
The global Herceptin (Trastuzumab) and Biosimilar market size is projected to grow from US$ 4413.9 million in 2022 to US$ 6202.2 million in 2029; it...
LPI
June 2023
Price: USD 3,660.00
The global Herceptin (Trastuzumab) and Biosimilar market size was valued at USD 4642.6 million in 2022 and is forecast to a readjusted size of USD...
GIR
June 2023
Price: USD 3,480.00
Trastuzumab– Biosimilar Insight, 2020 report provides comprehensive insights about 35+ companies and 35+ marketed and pipeline drugs in Trastuzumab...
Catalog: 
Delveinsight
September 2020
Price: USD 2,500.00
Summary The global Herceptin Biosimilar market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define,...
Catalog: 
HYR
January 2022
Price: USD 1,800.00
This Competitive Intelligence Report about Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin provides a competitor evaluation in the...
La Merie Publishing
February 2015
Price: USD 390.00
The present Competitive Intelligence Report about Her2 Antibodies - Trastuzumab Biosimilars and Biobetters/Biosuperiors provides a competitor...
La Merie Publishing
February 2014
Price: USD 413.00
This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competitor evaluation in the field...
La Merie Publishing
April 2015
Price: USD 1,500.00
Biosimilar and Biosuperior Therapeutic Antibodies 2014 The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic...
La Merie Publishing
March 2014
Price: USD 1,514.00
Bevacizumab– Biosimilar Insight, 2020 report provides comprehensive insights about 40+ companies and 40+ marketed and pipeline drugs in Bevacizumab...
Catalog: 
Delveinsight
September 2020
Price: USD 2,000.00

Contact Us for Custom Market Research Solutions

 

Filter By Industry

Filter By Country

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected